Skip to main content
Raaj Medisafe India Limited logo

Raaj Medisafe India Limited — Investor Relations & Filings

Ticker · 524502 ISIN · INE548H01015 LEI · 335800MH52JF3K1KPR38 BSE.NS Manufacturing
Open in API
Filings indexed 5 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country IN India
Listing BSE.NS 524502

About Raaj Medisafe India Limited

https://www.raajmedisafeindia.com

Raaj Medisafe India Limited specializes in the manufacturing and distribution of high-quality medical disposable products. The company's primary product portfolio includes a wide range of sterile single-use syringes, hypodermic needles, and infusion sets. Utilizing advanced manufacturing technologies and adhering to international quality standards such as ISO and CE certifications, the company ensures the safety and reliability of its medical consumables. Raaj Medisafe serves a diverse clientele across the healthcare spectrum, including hospitals, clinics, and diagnostic centers. Its commitment to precision engineering and sterile production environments positions it as a key supplier in the medical device market, focusing on enhancing patient safety through the provision of dependable, contamination-free medical supplies.

Recent filings

Filing Released Lang Actions
We attach herewith Statement of Deviation/Variation under Regulation 32 (1) of SEBI (LODR) Regulations, 2015
Regulatory Filings Classification · 75% confidence The document is an exchange filing under SEBI (Listing Obligations and Disclosure Requirements) Regulation 32, providing a “Statement of Deviation or Variation in utilization of funds raised through Preferential Issue” for the quarter ended March 31, 2026. It contains no new financial statements, strategic presentation, or officer certification, nor is it announcing management changes, dividends, legal actions, or an earnings release. It is a routine compliance disclosure to the stock exchange. This falls under the general “Regulatory Filings” category (RNS) as a catch-all for miscellaneous regulatory announcements that are not captured by more specific company report types.
2026-05-29 English
We attach herewith the following: a. Declaration of unmodified opinion b. Audited Financial Results for he quarter/year ended March 31, 2026, Declaration of unmodified opinion, Auditors ....
Interim / Quarterly Report Classification · 90% confidence The document is a substantive filing of audited financial results under SEBI Listing Regulations, containing an auditor’s report, declaration, detailed profit & loss, statement of assets & liabilities and cash flow for the quarter and year ended March 31, 2026. It exceeds a simple announcement, provides full financial statements, and is not a full annual report with MD&A. It fits the definition of an Interim / Quarterly Report (IR). FY 2026
2026-05-29 English
The Board of Directors of the Company in its meeting held on May 29, 2026 has inter-alia approved the following: a. Audited Financial Statements and cash Flow Statements for the year ....
Regulatory Filings Classification · 82% confidence The document is a formal letter to the stock exchange reporting the outcomes of a Board of Directors meeting (resolutions passed, financial results approved, share capital audit noted, etc.). It does not detail a change in directors or management (so not MANG), nor is it the full annual or interim financial report itself. It is also not a simple notice of report publication but an official regulatory submission of board decisions. Therefore, it falls under general Regulatory Filings (RNS).
2026-05-29 English
We attach herewith Annual Secretarial Compliance Report for the year ended March 31, 2026.
Regulatory Filings Classification · 85% confidence The document is a letter submitting the Annual Secretarial Compliance Report for the year ended March 31, 2026, prepared by a practicing company secretary under SEBI LODR Regulation 24A. It is an attestation/certification of compliance rather than a full financial report or earnings release. Under our rules, officer certifications and compliance certificates fall into the Regulatory Filings (RNS) category.
2026-05-29 English
Raaj Medisafe India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Please be informed that ....
Board/Management Information Classification · 75% confidence The document is a formal notice to the stock exchange announcing the date, time, venue, and agenda of an upcoming Board of Directors meeting. It does not contain financial statements itself nor report on results, but is an announcement related to corporate governance and board/management processes. This best fits under Board/Management Information (MANG).
2026-05-20 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.